Terms: = Thyroid cancer AND MUC16, CA125, CA-125 AND Treatment
19 results:
1. Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks.
Qu N; Chen D; Ma B; Zhang L; Wang Q; Wang Y; Wang H; Ni Z; Wang W; Liao T; Xiang J; Wang Y; Jin S; Xue D; Wu W; Wang Y; Ji Q; He H; Piao HL; Shi R
Nat Commun; 2024 Apr; 15(1):3175. PubMed ID: 38609408
[TBL] [Abstract] [Full Text] [Related]
2. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
Chen M; Zhang X; Ming Z; Lingyu ; Feng X; Han Z; An HX
J Transl Med; 2024 Mar; 22(1):315. PubMed ID: 38539235
[TBL] [Abstract] [Full Text] [Related]
3.
Alamri AM; Alkhilaiwi FA; Khan NU; Tasleem M
Anticancer Agents Med Chem; 2023; 23(19):2111-2126. PubMed ID: 37287303
[TBL] [Abstract] [Full Text] [Related]
4. A case report of anterior mediastinal signet ring cell carcinoma.
Liu S; Zhao A; Mao M
Medicine (Baltimore); 2022 Dec; 101(48):e32202. PubMed ID: 36482538
[TBL] [Abstract] [Full Text] [Related]
5. Advantages and clinical significance of enhanced CT combined with BRAF V600E gene detection in the diagnosis of papillary thyroid carcinoma.
Zhang J; Zhang J; Han J
Med Eng Phys; 2022 Dec; 110():103862. PubMed ID: 35933302
[TBL] [Abstract] [Full Text] [Related]
6. Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment.
Moskovich D; Finkelshtein Y; Alfandari A; Rosemarin A; Lifschytz T; Weisz A; Mondal S; Ungati H; Katzav A; Kidron D; Mugesh G; Ellis M; Lerer B; Ashur-Fabian O
Oncogene; 2021 Nov; 40(44):6248-6257. PubMed ID: 34556811
[TBL] [Abstract] [Full Text] [Related]
7. Hyperthyroidism associated with
Podfigurna A; Szeliga A; Horwat P; Maciejewska-Jeske M; Meczekalski B
Gynecol Endocrinol; 2021 Dec; 37(12):1143-1150. PubMed ID: 34387530
[TBL] [Abstract] [Full Text] [Related]
8. Papillary thyroid carcinoma in Struma Ovarii.
Khatchapuridze K; Kekelidze N; Tsitsishvili Z; Mchedlishvili M; Kordzaia D
Gynecol Endocrinol; 2020 Aug; 36(8):749-752. PubMed ID: 32041443
[TBL] [Abstract] [Full Text] [Related]
9. Ovarian metastases reported after adjuvant laparoscopic oophorectomies in breast cancer.
Cristian DA; Grama FA; Becheanu G; Popa I; Bratu AM; Burcoş T; Poalelungi CV; Şurlin V
Rom J Morphol Embryol; 2019; 60(3):913-920. PubMed ID: 31912104
[TBL] [Abstract] [Full Text] [Related]
10. Ovarian cancer metastasis to the breast 18 years after the initial diagnosis: A case report.
Wang Z; Zhao D; Liu R; Zheng B
Medicine (Baltimore); 2019 Oct; 98(43):e17577. PubMed ID: 31651861
[TBL] [Abstract] [Full Text] [Related]
11. [Benign struma ovarii: Report of 7 cases and review of the literature].
Lamblin G; Gallice C; Bournaud C; Nadaud B; Lebail-Carval K; Chene G
Gynecol Obstet Fertil; 2016 May; 44(5):263-8. PubMed ID: 26997461
[TBL] [Abstract] [Full Text] [Related]
12. METASTATIC RADIOIODINE AVID STRUMA OVARII ASSOCIATED WITH PSEUDO-MEIGS' SYNDROME.
Riaz S; Bashir H; Hassan A; Syed AA; Hussain M; Imtiaz S
J Ayub Med Coll Abbottabad; 2015; 27(3):731-4. PubMed ID: 26721055
[TBL] [Abstract] [Full Text] [Related]
13. [Clinical study on 68 cases with struma ovarii].
Wang Y; Pan L; Huang H; Shen K; Wu M; Lang J
Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):451-4. PubMed ID: 25169639
[TBL] [Abstract] [Full Text] [Related]
14. Unilateral malignant struma ovarii in a case of bilateral ovarian teratoma with raised ca-125 level: a rare case with treatment dilemmas.
Menon S; Deodhar K; Rekhi B; John A; Maheshwari A
Indian J Pathol Microbiol; 2011; 54(3):578-80. PubMed ID: 21934226
[TBL] [Abstract] [Full Text] [Related]
15. Ovarian tumors with elevated ca-125 levels and severe juvenile hypothyroidism: a need for increased awareness.
Krishnamurthy S; Seth A; Puri A; Anand R; Aneja S
Indian J Pediatr; 2010 Jun; 77(6):693-4. PubMed ID: 20532693
[TBL] [Abstract] [Full Text] [Related]
16. Use of common seric tumor markers in patients with solid cancers.
Gara S; Boussen H; Ghanem A; Guemira F
Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
[TBL] [Abstract] [Full Text] [Related]
17. Increased levels of tumor markers in the follow-up of 400 patients with breast cancer without recurrence or metastasis: interpretation of false-positive results.
Zervoudis S; Peitsidis P; Iatrakis G; Panourgias E; Koureas A; Navrozoglou I; Dubois JB
J BUON; 2007; 12(4):487-92. PubMed ID: 18067207
[TBL] [Abstract] [Full Text] [Related]
18. Coexistence of Graves' disease and benign struma ovarii in a patient with marked ascites and elevated ca-125 levels.
Guida M; Mandato VD; Di Spiezio Sardo A; Di Carlo C; Giordano E; Nappi C
J Endocrinol Invest; 2005 Oct; 28(9):827-30. PubMed ID: 16370564
[TBL] [Abstract] [Full Text] [Related]
19. Repeated 131I treatment of a residual ovarian teratoma containing malignant thyroid tissue.
Suga K; Hirabayashi A; Motoyama K; Kume N; Matsunaga N; Tamura H; Kato H
Br J Radiol; 1999 Nov; 72(863):1110-3. PubMed ID: 10700830
[TBL] [Abstract] [Full Text] [Related]
